Practical stability screening workflows help researchers accelerate biologics formulation development.
Developing stable biologic formulations requires more than particle size measurements alone. Rather, successful formulation development depends on understanding thermal stability, propensity for aggregation, and intermolecular interactions to identify potential risks early and make informed development decisions.
This free toolkit brings together three practical application notes that demonstrate how complementary analytical techniques can support faster, more confident formulation development. Discover how dynamic light scattering (DLS), differential scanning fluorimetry (DSF), and static light scattering (SLS) can be used to evaluate protein stability, compare formulation conditions, and streamline biologics research and development.
What you'll learn
By downloading this toolkit, you'll discover how to:
- Screen formulation conditions more efficiently
- Identify stability risks earlier in development
- Compare candidate formulations with greater confidence
- Assess colloidal and thermal stability using complementary techniques
- Reduce sample consumption while increasing analytical insight
- Accelerate formulation optimization and candidate selection
Included in this toolkit
Rapid assessment of monoclonal antibody stability
Learn how multiple stability indicators can be used to evaluate monoclonal antibody formulations and support data-driven development decisions.
Complete characterization of antibody formulations: A practical case study
Explore a real-world case study demonstrating how particle size, aggregation behavior, thermal stability, and intermolecular interactions can be assessed within a unified workflow.
Accelerating protein formulation development: pH-dependent stability analysis of lysozyme
Discover how complementary stability measurements can reveal critical formulation differences that may not be apparent from particle sizing alone.
Who should download this toolkit?
This resource is designed for:
- Biologics scientists
- Biopharmaceutical researchers
- Formulation scientists
- Protein characterization specialists
- Analytical scientists
- Drug discovery teams
- Process development scientists
- CRO and CDMO researchers
Why it matters
Early formulation decisions can significantly influence the success of a biologics program. By combining measurements of protein size, thermal stability, aggregation behavior, and intermolecular interactions, researchers can gain a more complete understanding of formulation performance and make better-informed development decisions.
This toolkit showcases practical workflows that help scientists evaluate stability with greater confidence while improving throughput and reducing analytical complexity.
Download your complimentary toolkit
Gain practical insights into biologics stability screening and discover how integrated analytical workflows can help accelerate formulation development, reduce risk, and improve confidence in candidate selection.
About Malvern Panalytical
Malvern Panalytical, together with Micromeritics Instrument Corporation and SciAps, represents a powerful and highly complementary combination of market-leading technologies. We bring together decades of scientific expertise to deliver advanced analytical solutions that measure the chemical, physical, and structural properties of materials - from proteins and polymers to batteries, catalysts, semiconductors, and minerals.
- Malvern Panalytical specializes in particle characterization, X-ray diffraction (XRD), X-ray fluorescence (XRF), and molecular interaction analysis.
- Micromeritics is a global leader in surface area and porosity analysis, particle characterization, and density measurement solutions.
- SciAps delivers portable, high-performance XRF and Raman analyzers for field-based elemental and materials analysis.
With more than 92,000 systems installed worldwide and operations across North America, Europe, and Asia, our technologies help customers accelerate innovation, optimize processes, and ensure quality across industries including pharmaceuticals, advanced materials, energy storage, chemicals, metals, mining, and environmental science.
As part of Spectris plc, we are committed to sustainability, customer support excellence, and enabling a cleaner, healthier, and more productive world.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.net, which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.